Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug recommended by NICE for stroke prevention

  • Comment

The National Institute for Health and Clinical Excellence (NICE) has recommended the oral anticoagulant dabigatran (Pradaxa) as an option for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Data showed dabigatran 150mg twice daily was more effective than warfarin, and 110mg twice daily was as effective as warfarin, NICE said.

It added that decisions on starting treatment with dabigatran should be made after discussion about its risks and benefits compared with warfarin, and in light of a patient’s current level of international normalised ratio control.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.